A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age
Part of paid clinical trials in Tempe, Arizona.
- Sponsor
- Icosavax, Inc.
- Study ID
- NCT05903183
- Phase
- PHASE2
- Status
- Completed
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- IVX-A12 — BIOLOGICALIVX-A12 without adjuvant
- IVX-A12 — BIOLOGICALIVX-A12 with adjuvant
- Placebo — BIOLOGICALDiluent
Study Details
The primary purpose of the study is to assess the safety, tolerability and immunogenicity of a bivalent respiratory syncytial virus (RSV)/human metapneumovirus (hMPV) virus-like particle (VLP) candidate vaccine (IVX-A12) compared to placebo, when administered as a single-dose regimen in healthy older adults 60 to 85 years of age.
Key Dates
- First listed
- Jun 15, 2023
- Start date
- May 15, 2023
- Status verified
- Nov 2025
- Primary completion
- Jun 5, 2023
- Completion
- Oct 25, 2024
Study Design
- Enrollment
- 264 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: IVX-A12 Vaccine Formulation 1Participants will receive a single dose of IVX-A12 intramuscular (IM) injection on Day 0.
- Experimental: IVX-A12 Vaccine Formulation 2Participants will receive a single dose of IVX-A12 IM injection on Day 0.
- Placebo Comparator: PlaceboParticipants will receive a single dose of placebo IM injection on Day 0.
Primary Outcome Measure
Number of Participants With Solicited Local Adverse Reactions (ARs) and Systemic ARs [ Time Frame: From Day 0 to Day 6 ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| AMR Phoenix | Tempe | Arizona | 85281 | - |
| Cenexel RCA | Hollywood | Florida | 33024 | - |
| Clinical Research Atlanta | Stockbridge | Georgia | 30281 | - |
| Velocity Clinical Research-Boise | Meridian | Idaho | 83642 | - |
| ASR, LLC | Nampa | Idaho | 83587 | - |
| Johnson City Clin-Trials (JCCT) | Lenexa | Kansas | 66219 | - |
| AMR Lexington | Lexington | Kentucky | 40509 | - |
| Velocity Clinical Research | Omaha | Nebraska | 68134 | - |
| Rochester Clinical Research, Inc | Rochester | New York | 14609 | - |
| PanAmerican Clinical Research | Brownsville | Texas | 78520 | - |
Find similar trials in Tempe, AZ
Related Studies
- Evaluation and Optimization of Ultrasound and/or MRI Hardware and SoftwareRecruiting · State University of New York - Upstate Medical University · Syracuse, New York
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated DonorsPHASE3 · Recruiting · Center for International Blood and Marrow Transplant Research · Boca Raton, Florida
- Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis MethodsEnrolling By Invitation · Memorial Sloan Kettering Cancer Center · New York, New York
- Skin Microbial Ecology in Atopic DermatitisRecruiting · University of Rochester · Rochester, New York